Cargando…
Nanobodies targeting ABCC3 for immunotargeted applications in glioblastoma
The cancer “omics” reveal many clinically relevant alterations that are transforming the molecular characterization of glioblastomas. However, many of these findings are not yet translated into clinical practice due, in part, to the lack of non-invasive biomarkers and the limitations imposed by the...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group UK
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9803684/ https://www.ncbi.nlm.nih.gov/pubmed/36585418 http://dx.doi.org/10.1038/s41598-022-27161-3 |